TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
LLY

Eli Lilly and Company

Healthcare · Drug Manufacturers - General

1,152.40$ +1.3% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LLY
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
17.66 18.06 19.28 18.99 20.79 23.31 25.65 29.69 30.04 37.78 49.82 72.58
4.44 4.56 5.19 4.23 4.53 4.93 5.73 7.67 6.98 7.84 9.31 11.76
13.22 13.50 14.09 14.76 16.26 18.38 19.92 22.03 23.06 29.94 40.51 60.82
4.26 4.34 4.82 4.84 4.89 5.84 6.25 7.27 7.57 10.31 12.16 14.85
5.96 5.91 5.75 5.87 5.55 6.27 6.14 6.44 6.39 7.68 9.00 12.35
10.22 10.25 10.57 10.72 10.43 12.11 12.38 13.71 13.95 18.00 21.15 27.75
3.00 3.25 3.52 4.04 5.83 6.27 7.54 8.32 9.11 11.94 19.36 33.07
0.13 0.15 0.17 0.21 0.23 0.42 0.38 0.36 0.35 0.54 0.86 0.89
2.70 2.52 3.06 2.19 3.56 5.50 7.56 6.45 7.16 7.26 14.03 28.65
0.55 0.35 0.58 2.27 0.51 0.66 1.08 0.60 0.59 1.45 2.31 5.67
2.15 2.18 2.49 -0.19 3.13 8.69 6.47 5.85 6.57 5.80 11.71 22.98
4.08 3.96 4.59 3.89 5.35 7.21 9.32 8.43 9.11 9.49 16.84 31.11

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?